The influence of reactivation of the telomerase in tumour tissue on the prognosis of squamous cell carcinomas in the head and neck

被引:14
作者
Koscielny, S
von Eggeling, F
Dahse, R
Fiedler, W
机构
[1] Univ Jena, ENT Dept, D-07740 Jena, Germany
[2] Univ Jena, Inst Human Genet & Anthropol, D-07740 Jena, Germany
[3] Univ Halle Wittenberg, Halle Saale, Germany
关键词
head and neck cancer; head and neck surgery; prognosis; recurrences; telomerase;
D O I
10.1111/j.1600-0714.2004.00232.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
BACKGROUND: The reactivation of the telomerase seems to be an important step in the carcinogenesis of most human cancer types. Cell clones, which express this enzyme, get the ability of indefinite proliferation, means become immortal. METHODS: In this study, 80 patients with squamous cell carcinomas (SSC) in oral cavity, oropharynx, hypopharynx and larynx were recorded prospectively concerning a possible correlation of telomerase activity and clinical and prognostic factors. Telomerase activity was analysed by a modified telomeric repeat amplification protocol (TRAP) assay. RESULTS: In 75% of the tumour tissues the telomerase was demonstrated independently of the localization of the tumour. The known clinical prognostic factors did not show any correlation to the expression rate of the telomerase activity in the tumour tissues. Also, reactivated telomerase did not affect the tumour-dependent survival. Only the number of lymph node metastases was in tendency higher in patients with telomerase-positive tumours. The number and timeframe of local and regional recurrences was not influenced by the telomerase status. CONCLUSIONS: Although telomerase seems to be an important part of the carcinogenesis of SCC our data show that the reactivation of telomerase in tumour tissue did not have any prognostic significance for these tumours. The tendency that tumours with active telomerase developed lymph node metastases in a higher number should be evaluated by further enlarged studies for its clinical relevance.
引用
收藏
页码:538 / 542
页数:5
相关论文
共 24 条
[1]  
Bièche I, 2000, CLIN CANCER RES, V6, P452
[2]   Telomerase activity and prognosis in primary breast cancers [J].
Carey, LA ;
Kim, NW ;
Goodman, S ;
Marks, J ;
Henderson, G ;
Umbricht, CB ;
Dome, JS ;
Dooley, W ;
Amshey, SR ;
Sukumar, S .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (10) :3075-3081
[3]   Telomerase activity is upregulated in laryngeal squamous cell carcinoma [J].
Curran, AJ ;
Gullane, PJ ;
Irish, J ;
Macmillan, C ;
Freeman, J ;
Kamel-Reid, S .
LARYNGOSCOPE, 2000, 110 (03) :391-396
[4]   Detection of telomerase in hepatocellular carcinomas using a PCR ELISA assay:: comparison with hTR expression [J].
Ferlicot, S ;
Paradis, V ;
Dargère, D ;
Monges, G ;
Bedossa, P .
JOURNAL OF CLINICAL PATHOLOGY, 1999, 52 (10) :725-729
[5]  
Fiedler W, 1996, INT J ONCOL, V9, P1227
[6]   Cell senescence in human aging and disease [J].
Fossel, M .
INCREASING HEALTHY LIFE SPAN: CONVENTIONAL MEASURES AND SLOWING THE INNATE AGING PROCESS, 2002, 959 :14-23
[7]   Telomerase activity in human renal cell carcinoma [J].
Fujioka, T ;
Hasegawa, M ;
Suzuki, Y ;
Suzuki, T ;
Sugimura, J ;
Tanji, S ;
Koike, H .
INTERNATIONAL JOURNAL OF UROLOGY, 2000, 7 (01) :16-21
[8]  
Halvorsen OJ, 2000, CANCER, V88, P416, DOI 10.1002/(SICI)1097-0142(20000115)88:2<416::AID-CNCR24>3.3.CO
[9]  
2-R
[10]  
Harley CB, 1997, CANCER SURV, V29, P263